Evidence map›Paper›PMID 41233507›Full record

ArticleNPJ digital medicine2025

AI-driven prediction of progression to oral squamous cell carcinoma using a multiresolution pathology model.

Yingci Liu-Swetz, Sead Niksic, Raja R Seethala, Alivia Shasteen, David J Foran, Elizabeth A Bilodeau

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yingci Liu-SwetzRutgers Health (Rutgers University), Newark, NJ, USA. yingci.liu@rutgers.edu.
Sead NiksicRutgers Health (Rutgers University), Newark, NJ, USA.
Raja R SeethalaUniversity of Pittsburgh/UPMC, Pittsburgh, PA, USA.
Alivia ShasteenUniversity of Pittsburgh/UPMC, Pittsburgh, PA, USA.
David J ForanRutgers Health (Rutgers University), Newark, NJ, USA.
Elizabeth A BilodeauUniversity of Pittsburgh/UPMC, Pittsburgh, PA, USA.

Funding

NJ ACTS: A Platform for Translational Science in New Jersey: CTSA K12 Program at Rutgers, Biomedical Health SciencesK12TR004788 · NCATS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI John R. Chan, Ethan A Halm · 2024 to 2026
$2.8M
NCATS NIH HHS K12 TR004788NCATS NIH HHS K12TR004788
6 · The paper itself

Abstract

Potentially malignant oral lesions are visible mucosal changes with risk of progressing to squamous cell carcinoma. These lesions are currently graded as no, mild, moderate, or severe dysplasia per WHO guidelines. While widely used, this system is subjective, imprecise, and limited in distinguishing low-risk from high-risk lesions. To address this, we developed a multiresolution deep learning model using digital pathology to predict malignant transformation. Trained on 221 digitized whole-slide images (111 progressors, 110 non-progressors), our vision transformer (ViT) model outperformed traditional CNN-based models, achieving 80.0% accuracy, an F1-score of 77.3%, and an AUROC of 0.798. Importantly, AI-predicted progression aligned with histopathologic features such as abnormal keratinization, increased apoptosis, and nuclear changes characteristic of malignancy. While further validation in larger, prospective cohorts is needed, our model demonstrates promise as an adjunctive tool for identifying high-risk lesions, potentially improving risk stratification, and guiding treatment decisions.

Identifiers

PMID41233507
PMCPMC12615645

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.